Global Artificial Intelligence (AI) In Respiratory Diseases Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Artificial Intelligence (AI) In Respiratory Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Artificial Intelligence (AI) In Respiratory Diseases Market Size and Projected Growth Rate?
In recent times, there has been robust growth in the market size for artificial intelligence (AI) applied to respiratory diseases. We forecast an expansion from $7.66 billion in 2024 to $8.05 billion in 2025, marking a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth in the past include heightened government regulations, escalating environmental issues, a rise in the aging population, the increase in healthcare strategies centered around patients, and the upsurge in healthcare infrastructure development.

Anticipated to see a vigorous boom in the upcoming years, the market size of artificial intelligence (AI) in respiratory diseases is projected to reach $9.85 billion in 2029, with a compound annual growth rate (CAGR) of 5.2%. The predicted growth during the forecast period is as a result of the escalating occurrence of respiratory disorders, the urgent requirement for early recognition and diagnosis, the expanding environmental pollution, growing expenses in healthcare, and the initiatives in research and development. The forecast period is marked by major trends such as technological progression, drug innovation and betterment, customized treatment agendas, telehealth, and distant patient supervision.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792

What Are the Major Segments in the Artificial Intelligence (AI) In Respiratory Diseases Market?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented -

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

What Are The Driving Artificial Intelligence (AI) In Respiratory Diseases Market Evolution?
The rise in environmental pollution is anticipated to fuel the growth of artificial intelligence (AI) in the respiratory disease market. This type of pollution involves the release of substances or energy into the environment at a pace faster than they can be dispersed or neutralized. AI in respiratory diseases may significantly mitigate the effects of environmental pollution on respiratory health by providing real-time tracking, personalised risk evaluation, informed decision-making abilities, and innovative solutions for both individuals and communities. As an example, data from the US Energy Information Administration revealed that CO2 emissions rose from 35.72 billion metric tons in 2021 to 38.50 billion metric tons in 2022 as stated in June 2024. Consequently, the escalating environmental pollution is catalysing the expansion of artificial intelligence (AI) in the respiratory disease market.

Which Firms Dominate The Artificial Intelligence (AI) In Respiratory Diseases Market Segments?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

What Trends Are Expected to Dominate the Artificial Intelligence (AI) In Respiratory Diseases Market in the Next 5 Years?
Key industry players in the realm of artificial intelligence (AI) for respiratory disease management are stepping up innovation by creating products like the N-Tidal devices, designed to monitor tidal breathing in patients. These devices quantify the amount of air circulated during ordinary respiration, offering essential insights into lung performance. For example, UK-based respiratory tech firm TidalSense released N-Tidal in August 2023, an AI-powered regulation technology purposed for the diagnosis and handling of chronic obstructive pulmonary disease (COPD). N-Tidal's CO2 sensor data is utilized alongside an AI system to assess changes in lung function, intending to enhance COPD diagnosis and management. The high precision of the technology has been validated by clinical trials, suggesting a potential transformation in the diagnosis methodology for respiratory diseases. The inception of this technology symbolizes a notable advancement in employing AI for assessing respiratory illnesses, presenting a more relaxed and effective substitute to prevailing diagnostic procedures.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Which Is The Largest Region In The Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Artificial Intelligence (AI) In Respiratory Diseases Market?
2. What is the CAGR expected in the Artificial Intelligence (AI) In Respiratory Diseases Market?
3. What Are the Key Innovations Transforming the Artificial Intelligence (AI) In Respiratory Diseases Industry?
4. Which Region Is Leading the Artificial Intelligence (AI) In Respiratory Diseases Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.